Tivic reports year end 2024 financial results and provides overview of strategy for transformation and growth

Fremont, calif.--(business wire)--tivic health® systems, inc. (nasdaq: tivc), a diversified therapeutics company, today announced year end december 31, 2024 financial results, highlighted key developments in its clinical program expansion and discussed progress made across the company's operations. “the important strategic events of the past several months have been nothing short of transformative,” stated tivic health chief executive officer, jennifer ernst. “we have successfully reshaped the.
TIVC Ratings Summary
TIVC Quant Ranking